BioSyntech Inc.: Dr. Michael Buschmann to Receive the Innovator Prize for 2004 from ADRIQ.LAVAL, Quebec -- BIOSYNTECH (TSX Venture Exchange TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. :BSY BSY Busy BSY British School of Yoga BSY Bit Sync BSY Busy Line ) is pleased to announce that Michael D. Buschmann, Professor of Chemical Engineering and Biomedical Engineering Biomedical engineering An interdisciplinary field in which the principles, laws, and techniques of engineering, physics, chemistry, and other physical sciences are applied to facilitate progress in medicine, biology, and other life sciences. at Ecole Polytechnique and Vice-President, Discovery at BioSyntech will receive the Innovator Prize for 2004 from the Association of Industrial Research of Quebec (ADRIQ ADRIQ Association de la Recherche Industrielle du Québec (Canada) ) at the 14th ADRIQ Gala in Montreal on November 25 (http://www.adriq.com/prix/index.html). This award is given in recognition of innovation in research that leads to important advancements in industry. Dr. Buschmann's contributions to BioSyntech's technology platform (BST-Gel(TM)), cartilage repair product (BST-CarGel(TM)) and clinical instrumentation for cartilage diagnosis (Arthro-BST(TM)) were found to be significant innovations worthy of ADRIQ's 2004 Innovator Prize. In fact, preparations are well-underway for commencement of a multi-center Canadian-European trial for BST-CarGel(TM) following approval by Health Canada. About BioSyntech - BioSyntech is a biotechnology company specializing in the discovery, development and manufacturing of innovative cost-effective and physician-friendly biologic-implants for regenerative medicine and therapeutic delivery. BioSyntech's Quality Management System is registered to ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 and ISO 13485:2001. For additional information, visit www.biosyntech.com. NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. BioSyntech Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension VENTURE:BSY) |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion